Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H16ClNO3 |
Molecular Weight | 305.756 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OCC2=CC=CN=C2
InChI
InChIKey=RARQHAFNGNPQCZ-UHFFFAOYSA-N
InChI=1S/C16H16ClNO3/c1-16(2,21-14-7-5-13(17)6-8-14)15(19)20-11-12-4-3-9-18-10-12/h3-10H,11H2,1-2H3
Molecular Formula | C16H16ClNO3 |
Molecular Weight | 305.756 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Nicofibrate is an antilipidemic drug. Treatment of diabetics led to a significant reduction in plasma cholesterol and triglycerides and brought the lipoprotein picture back within the norm. Nicofibrate did not lead to significant increases in uricaemia nor to any worsening in carbohydrate tolerance. Nicofibrate may also lead to a significant drop in plasma prothrombinic activity.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:56:53 GMT 2023
by
admin
on
Fri Dec 15 15:56:53 GMT 2023
|
Record UNII |
4839MB71E7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C98150
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID90185815
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
1915
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
100000084171
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
C75259
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
4839MB71E7
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
31980-29-7
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106799
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
65778
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
3388
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
250-880-7
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
SUB09236MIG
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | |||
|
m364
Created by
admin on Fri Dec 15 15:56:53 GMT 2023 , Edited by admin on Fri Dec 15 15:56:53 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |